Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
RZLT
Stock Latest News
Pre-Earnings
Rezolute, Inc. (RZLT) Q4 Earnings Cheat Sheet
5d ago
RZLT
Premium
Ratings
Rezolute’s Promising Future: FDA Approval and Strategic Valuation Drive Buy Rating
11d ago
RZLT
Premium
Ratings
Rezolute’s Ersodetug Gains Momentum with FDA Support and Increased Success Probability, Raising Price Target
11d ago
RZLT
Premium
Ratings
Rezolute’s Ersodetug Gains Momentum with FDA Streamlined Phase 3 Design and Promising Efficacy in Tumor-Induced Hyperinsulinism
12d ago
RZLT
Premium
The Fly
Rezolute announces alignment with FDA on design for Phase 3 trial of ersodetug
12d ago
RZLT
Premium
Company Announcements
Rezolute Aligns with FDA on Phase 3 Trial Design
12d ago
8K
RZLT
Premium
The Fly
Rezolute appoints Karnawat as Chief Commercial Officer
25d ago
CYTK
RARE
Premium
Company Announcements
Rezolute Appoints New Chief Commercial Officer
25d ago
8K
RZLT
Premium
Company Announcements
Rezolute Completes Enrollment for Phase 3 sunRIZE Study
2M ago
8K
RZLT
Premium
The Fly
Rezolute files to sell 1.3M shares of common stock for holders
2M ago
RZLT
Premium
Ratings
Promising Future for Rezolute’s Ersodetug in Treating Congenital Hyperinsulinism: Analyst Recommends Buy
2M ago
RZLT
Premium
Ratings
Positive Buy Rating for Rezolute Driven by Promising Phase 3 Study Results and Strong Efficacy Potential
2M ago
RZLT
Premium
Company Announcements
Rezolute Completes Private Stock Placement for $4.2M
3M ago
8K
RZLT
Premium
Ratings
Rezolute’s Promising Outlook: Buy Rating Backed by Strong Clinical Progress and Financial Position
4M ago
RZLT
Premium
The Fly
Rezolute complete enrollment in Phase 3 sunRIZE study of ersodetug
4M ago
RZLT
Premium
Pre-Earnings
Rezolute, Inc. (RZLT) Q3 Earnings Cheat Sheet
4M ago
RZLT
Premium
Ratings
Rezolute’s Financial Stability and Clinical Progress Drive Buy Rating Amid Promising Phase 3 Trials
4M ago
RZLT
Premium
Ratings
Rezolute’s Promising Market Position and Clinical Advancements Drive Buy Rating
4M ago
RZLT
Premium
Ratings
Rezolute’s Ersodetug Shows Promise in Phase 3 Trials for CHI, Reinforcing Buy Rating and $12 Price Target
4M ago
RZLT
Premium
Ratings
Optimistic Buy Rating for Rezolute Driven by Promising Ersodetug Developments and Strong Financial Position
4M ago
RZLT
Premium
The Fly
Rezolute reports Q3 EPS (27c), consensus (24c)
4M ago
RZLT
Premium
Ratings
Rezolute’s Ersodetug Gains Momentum with Breakthrough Therapy Designation and Promising Market Potential
4M ago
RZLT
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
